about
Zika Virus Infection and Solid Organ Transplantation: A New Challenge.Nonsurgical periodontal therapy combined with laser and photodynamic therapies for periodontal disease in immunosuppressed rats.Microscopic evidences that bone marrow mononuclear cell treatment improves sciatic nerve regeneration after neurorrhaphy.Fetal microchimerism in kidney biopsies of lupus nephritis patients may be associated with a beneficial effect.Interleukin 2-dependent release of interleukin 3 activity by T4+ human T-cell clones.Individualizing early use of sirolimus in renal transplantation.The emerging role of Brazil in clinical trial conduct for transplantation.Repairing the chronic damaged kidney: the role of regenerative medicine.An Overview of the Current Status of Organ Donation and Transplantation in Brazil.HLA-A, -B, and -DRB1 allele and haplotype diversity in a cohort of Brazilian renal transplant candidates.Prediction, prevention, and management of delayed graft function: where are we now?Organ trafficking and transplant tourism: the role of global professional ethical standards-the 2008 Declaration of Istanbul.Expanding criteria for the use of living donors: what are the limits?Collaborative Brazilian Pediatric Renal Transplant Registry (CoBrazPed-RTx): A Report From 2004 to 2013.Induced Pluripotent Stem Cells Reduce Progression of Experimental Chronic Kidney Disease but Develop Wilms' Tumors.Comments on renal abnormalities of sickle cell disease.Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the myfortic prospective multicenter study.Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimus.Randomized trial of early corticosteroid reduction vs. regular-dose corticosteroid maintenance in combination with tacrolimus and mycophenolate mofetil in living donor kidney transplant recipients: the Brazilian CORRETA trial.Report of initial experience in small bowel transplantation at São José do Rio Preto Medical School Hospital.Corticosteroid reduction with tacrolimus (CORRETA) TRIAL: a prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus (Prograf) and mycophenolate mofetil (CInfluence of UDP-glucuronosyltransferase polymorphisms on mycophenolate mofetil-induced side effects in kidney transplant patients.Cutaneous leishmaniasis in kidney transplant recipient.Clinical and histopathologic comparative analysis between kidney transplant recipients from expanded-criteria donors and standard-criteria donors.Organ transplantation in numbers: Brazil reaches its goals. Preface.Natural killer cell response to interferons.Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study.Hyperhomocysteinemia and MTHFR C677T and A1298C polymorphisms are associated with chronic allograft nephropathy in renal transplant recipients.Organ transplantation in Brazil and Latin America: reaching the light at the end of the tunnel.Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure.Role of glutathione s-transferase polymorphisms and chronic allograft dysfunction.Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.Do we need living unrelated organ donation in Brazil?Variables associated to fetal microchimerism in systemic lupus erythematosus patients.Validation of an Experimental Model to Study Less Severe Chronic Renal Failure.Survey of concepts and attitudes among healthcare professionals towards organ donation and transplantation.Switch from cyclosporine to sirolimus as a treatment of acute renal failure complicating cardiogenic shock in a heart transplant recipientBrazilian Transplant Organ Association: A Positive Look at the Past DecadeComparative effects of mesenchymal stem cell therapy in distinct stages of chronic renal failureEffects of polyunsaturated fatty acids (PUFAs) in the treatment of experimental chronic renal failure
P50
Q33435370-7AE24CA9-73F3-48FE-BAFD-7DA0182BF60CQ33938744-C5F37E85-47CD-4B0F-B918-4ADBD211E033Q34132856-54BC7B6A-3CE6-4364-B746-C4F1A3D3EB18Q35559428-AA14B2A9-8132-459B-B83A-109E2E238FC8Q37552231-6B7CEDCC-3503-425F-AC55-0C736782347BQ37822152-E399CB92-1B89-46B0-B4B9-B605CD1A0B6DQ37888772-0ACF148E-CB2F-4D7A-BA7F-6254B902AF36Q37968803-ED9E63C3-4859-43B7-B9EF-358E3F91D804Q38574052-B11AD83A-D082-4EA0-9FDC-5C0CA57D6924Q38816090-A89E837A-D193-4A61-B2AD-D0F975DA27C3Q38829547-11438486-04BF-4D54-8F13-D0FF6A586E1BQ38961538-075B4A37-9D5C-4BD9-BF92-7EEAFAD9C8DCQ40504069-6B6191F6-7C82-4053-9C73-FD416FF4D65DQ40876994-3685C8F1-5FAF-4242-B6D9-14B7919B7193Q41440761-D2ED7C3D-0CF6-45EE-BFDE-BF119333EB60Q42127480-56DBE87A-FF42-40D4-A699-587A8244C128Q42623184-599CB4FB-8729-49A7-8BD5-37108D16E964Q42974160-27CC3B20-1F28-4A65-A624-9154AFEB669EQ43202800-85FBE44E-83A8-4BCB-B878-A0F98C2AC238Q43618997-7BF99AC7-165C-4FEC-B0C1-799102215F73Q43657281-4557E76D-1B56-4E68-BD10-2E7CD68206E3Q43718019-A91565F3-B643-4040-85C0-2116E5BAD2F7Q43992349-27089A88-AC6B-4ABC-9140-CC003E383F1BQ44184783-15EF9810-C009-44D8-963E-8C3538CAC2B6Q44428571-E62641D5-0A4D-43A2-A02D-84D7AECDC458Q44723160-4FD80419-6EF2-4C3B-9CE1-9BE8FC7EFE52Q45046021-69B8385F-372A-4BCA-B880-C28C18121584Q45248048-03500245-9027-4FE9-8342-37A74EDC2578Q45255965-6F6BFD98-F6A5-48BC-B30B-8369C3D429A2Q46613204-81C3338A-69F6-459C-8E95-CC91FD303AACQ46613233-4CE3B91A-0FF2-44A7-9895-D5005A79A5E1Q46843894-3D400332-1796-4C53-86B8-41DA35A59308Q50998728-65BD22A4-9ADD-4874-8E43-EE7F193F9113Q52900293-BF2B0897-A97A-48E2-9B6C-515D37C69B6FQ53134308-6145C3E0-1724-4F10-91C2-98D8AA1C974BQ53586464-0889362B-553A-43A0-BCB0-C8A942377BD9Q58358723-8822BEEA-9701-4317-AE6B-9F7FA3638EE8Q60196036-9BE0BAE5-BDA2-458D-B53F-023A700CD0F8Q60196043-8BB44175-9D4F-4B1A-A92B-D3DAE181DFDDQ60196052-E2F0B920-4DD9-44B3-B9D3-B6CD02AFB2F1
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Mario Abbud-Filho
@ast
Mario Abbud-Filho
@en
Mario Abbud-Filho
@es
Mario Abbud-Filho
@nl
Mario Abbud-Filho
@sl
type
label
Mario Abbud-Filho
@ast
Mario Abbud-Filho
@en
Mario Abbud-Filho
@es
Mario Abbud-Filho
@nl
Mario Abbud-Filho
@sl
altLabel
Filho MA Mario Abbud
@en
prefLabel
Mario Abbud-Filho
@ast
Mario Abbud-Filho
@en
Mario Abbud-Filho
@es
Mario Abbud-Filho
@nl
Mario Abbud-Filho
@sl
P1053
E-5525-2017
P106
P1153
7003695847
P21
P214
481146029420635820232
P31
P3829
P496
0000-0002-5079-9813
P735
P7859
viaf-481146029420635820232